F1000Prime » Article Recommendations » Neurological Disorders »

Peripheral Neuropathies Recommendations

To view Article Recommendations, you must have an active subscription.

If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.

If you think you should be able to access this content, please contact us.

New to F1000? See this week’s top article below for a free preview of a Recommendation.

Take the tour.

SECTION HEADS

Jonathan Glass

Center for Neurodegenerative Disorders, Emory University School of Medicine, Atlanta, GA, USA
Gerard Said

Féderation de Neurologie, Hôpital de LA Salpétrière, , France
Austin Sumner

Department of Neurology, Louisiana State University Health Sciences Center, New Orleans, LA, USA

Section Topics

» Autonomic neuropathy
» Clinical neurophysiology of the peripheral nervous system
» Compression and entrapment neuropathies
» Drug-induced and toxic neuropathies
» Infectious neuropathies
» Inflammatory neuropathies

» Inherited neuropathies
» Metabolic neuropathies
» Neuropathy and malignant disorders
» Neuropathy and monoclonal gammopathies
» Painful neuropathies
» Vasculitis and neuropathy

LATEST RECOMMENDATION

Chemotherapy-induced peripheral neuropathy is a major cause of morbidity and dose reduction for which there is very limited effective therapy. This randomized, double-blind, placebo-controlled crossover study suggests that use of duloxetine for 5 weeks significantly...

Patrick Y Wen and Eudocia Quant, Brigham & Women's Hospital, USA. F1000 Neurological Disorders

Score:

INDIVIDUAL SUBSCRIPTIONS

Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.

Start your personal subscription today.

Subscribe for $9.95/month

Take the tour.